Cleared Traditional

K952720 - AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOBIN CONTROL LEVELS I & II

K952720 is an FDA 510(k) clearance for AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOB..., manufactured by Aalto Scientific, Ltd.. The device is a Class 2 Hematology device with product code JPK cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K952720 · Aalto Scientific, Ltd. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1995
Decision
97d
Days
Class 2
Risk

K952720 is an FDA 510(k) clearance for the AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOBIN CONTROL LEVELS I & II. Classified as Mixture, Hematology Quality Control (product code JPK), Class II - Special Controls.

Submitted by Aalto Scientific, Ltd. (Vista, US). The FDA issued a Cleared decision on September 20, 1995 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Aalto Scientific, Ltd. devices

FDA 510(k) Submission Details - K952720

510(k) Number K952720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 1995
Decision Date September 20, 1995
Days to Decision 97 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 113d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JPK Device Classification - Class 2, Special Controls

Product Code JPK Mixture, Hematology Quality Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPK Mixture, Hematology Quality Control

All 163
Devices cleared under the same product code (JPK) and FDA review panel - the closest regulatory comparables to K952720.
COULTER LINEARITY CONTROL
K955334 · Coulter Corp. · Feb 1996
4C PLUS COULTER CELL CONTROL
K955016 · Coulter Corp. · Jan 1996
QBC CENTRIFUGAL HEMATOLOGY CONTROL
K954137 · R&D Systems, Inc. · Oct 1995
SF-CHECK
K952245 · Streck Laboratories, Inc. · Sep 1995
RETIC CONTROL-M HEMATOLOGY CONTROL/MULTIPLE
K943335 · R&D Systems, Inc. · Dec 1994
RETIC CONTROL-H HEMATOLOGY CONTROL/MULTIPLE
K943336 · R&D Systems, Inc. · Dec 1994